NFL Biosciences (XPAR:ALNFL) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALNFL NFL Biosciences SA XPAR:ALNFL
26 GF Score
Price €0.73
! 1 Warning Sign
View Full Analysis

What is NFL Biosciences Unearned Premiums?

Unearned Premiums only applies to insurance companies.

XPAR:ALNFL
26GF Score
NFL Biosciences SA XPAR:ALNFL
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NFL Biosciences Business Description

Other Exchanges 82F:Germany
Address 199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA is a French clinical-stage biopharmaceutical company focused on developing botanical drugs to treat addiction, with an initial emphasis on tobacco dependence. Its lead candidate, NFL-101, is a nicotine-free botanical drug derived from well-characterized natural tobacco leaf proteins, designed to reduce smoking addiction through an immune-based mechanism. The company also pursues other botanical and pharmaceutical agents targeting addictive behaviors. As a development-stage enterprise, NFL Biosciences does not yet market commercial products; its revenue model depends on advancing its pipeline through clinical trials, securing regulatory approvals, and ultimately licensing or commercializing its drug candidates. Its activities are based in France, where it conducts research and development, and it targets the global smoking-cessation market, addressing smokers seeking alternatives to existing nicotine replacement and pharmacological therapies.
26GF Score

Get the complete analysis for XPAR:ALNFL

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price